Organoids research progress in gynecological cancers: a bibliometric analysis DOI Creative Commons
Bing He, Haochuan Ma, Hongbo Yu

и другие.

Frontiers in Oncology, Год журнала: 2024, Номер 14

Опубликована: Окт. 28, 2024

Background Gynecological cancers (GC) pose a severe threat to the health and safety of women’s lives, organoids, as in-vitro research models, have demonstrated significant advantages in simulating tissue characteristics drug screening. In recent years, there has been rapid increase outcomes related organoids GC. However, no bibliometric study concerning. Methods Publications GC from 2010-2023 were retrieved Web Science Core Collection (WoSCC). We conducted analysis visualization using CiteSpace, VOSviewer, Bibliometrix R Package. This included spatiotemporal distribution, author, sources, references, keywords. Results A total 333 publications included. The number annual indicated an explosive phase development since 2019. USA was most important country terms cooperation, publication output, citation centrality. University California system ranked first productivity among institutions, HIPPO Y is relevant author field. CANCERS published documents, NATURE cited sources. Analysis Keywords References, it possible establish trend, find hotspots Conclusion delineated global landscapes progress trends research. emphasized that can effectively replicate original or tumors, providing good model for on tumor-related mechanisms showing screening efficacy clinical prediction. Additionally, preclinical they provide compelling evidence personalized therapy prediction patient responses.

Язык: Английский

Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches DOI Creative Commons

YiLin Luo,

Xin Yue Bai,

L.J. Zhang

и другие.

Drug Design Development and Therapy, Год журнала: 2024, Номер Volume 18, С. 2485 - 2529

Опубликована: Июнь 1, 2024

Abstract: Ferroptosis, a unique form of programmed cell death, is initiated by an excess iron accumulation and lipid peroxidation-induced damage. There growing body evidence indicating that ferroptosis plays critical role in the advancement tumors. The increased metabolic activity higher levels tumor cells make them particularly vulnerable to ferroptosis. As result, targeted induction becoming increasingly promising approach for cancer treatment. This review offers overview regulatory mechanisms ferroptosis, delves into mechanism action traditional small molecule inducers their effects on various In addition, latest progress inducing using new means such as proteolysis-targeting chimeras (PROTACs), photodynamic therapy (PDT), sonodynamic (SDT) nanomaterials summarized. Finally, this discusses challenges opportunities development ferroptosis-inducing agents, focusing discovering targets, improving selectivity, reducing toxic side effects. Keywords: inducers, molecules, PROTACs, PDT, SDT,

Язык: Английский

Процитировано

8

Deubiquitination by USP7 Stabilizes JunD and Activates AIFM2 (FSP1) to Inhibit Ferroptosis in Melanoma DOI
Jiaheng Xie,

Chenfeng Ma,

Songyun Zhao

и другие.

Journal of Investigative Dermatology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Dual-responsive nanoscale ultrasound contrast agent as an oxidative stress amplifier for enhanced DNA damage in BRCA-proficient ovarian cancer DOI Creative Commons

Jialu Zhang,

Xiaoxuan Wang,

Lu Guo

и другие.

Materials Today Bio, Год журнала: 2025, Номер unknown, С. 101761 - 101761

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Targeting ferroptosis suppressor protein 1 in cancer therapy: Implications and perspectives, with emphasis on head and neck cancer DOI
Jong‐Lyel Roh

Critical Reviews in Oncology/Hematology, Год журнала: 2024, Номер 202, С. 104440 - 104440

Опубликована: Июль 9, 2024

Язык: Английский

Процитировано

3

Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer DOI Creative Commons
Rui Bi, Li Chen, Mei Huang

и другие.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2024, Номер unknown, С. 189221 - 189221

Опубликована: Ноя. 1, 2024

Язык: Английский

Процитировано

2

Organoids research progress in gynecological cancers: a bibliometric analysis DOI Creative Commons
Bing He, Haochuan Ma, Hongbo Yu

и другие.

Frontiers in Oncology, Год журнала: 2024, Номер 14

Опубликована: Окт. 28, 2024

Background Gynecological cancers (GC) pose a severe threat to the health and safety of women’s lives, organoids, as in-vitro research models, have demonstrated significant advantages in simulating tissue characteristics drug screening. In recent years, there has been rapid increase outcomes related organoids GC. However, no bibliometric study concerning. Methods Publications GC from 2010-2023 were retrieved Web Science Core Collection (WoSCC). We conducted analysis visualization using CiteSpace, VOSviewer, Bibliometrix R Package. This included spatiotemporal distribution, author, sources, references, keywords. Results A total 333 publications included. The number annual indicated an explosive phase development since 2019. USA was most important country terms cooperation, publication output, citation centrality. University California system ranked first productivity among institutions, HIPPO Y is relevant author field. CANCERS published documents, NATURE cited sources. Analysis Keywords References, it possible establish trend, find hotspots Conclusion delineated global landscapes progress trends research. emphasized that can effectively replicate original or tumors, providing good model for on tumor-related mechanisms showing screening efficacy clinical prediction. Additionally, preclinical they provide compelling evidence personalized therapy prediction patient responses.

Язык: Английский

Процитировано

0